Clin2
NCT05748015Possibly a fitRecruiting

Checking how the nervous system is affected in multiple sclerosis

Multiple Sclerosis

Part of Brain & nervous system, Immune system & allergy clinical trials.

This study looks at signs of how your automatic “control” nerves (the autonomic nervous system) may be affected in people with multiple sclerosis. It may help researchers better understand different types of MS and how to recognize nervous-system involvement.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with multiple sclerosis (MS) and your type is either relapsing-remitting or primary progressive.
  • Your MS is not a different MS type than those listed.
  • You do not have another known neurological condition besides MS.
  • You are not taking any drugs or substances that could harm the nervous system (neurotoxic substances).
  • You can follow the study’s planned testing/assessment to measure nervous-system involvement.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07012135Recruiting
Autonomic Function in Multiple Sclerosis

This study looks at how the nervous system controls automatic body functions (like heart rate and blood pressure) in people with multiple sclerosis. Researchers want to compare results between people with MS and healthy volunteers to understand how MS affects these functions.

Rochester, Minnesota
NCT07723599Not yet recruiting
Aging and nerve repair in multiple sclerosis

This study looks at how aging affects the brain's ability to repair the protective coating around nerves (myelin) in people with MS. It tests methods to measure this repair process and may help find ways to slow down disability.

Seattle, Washington
NCT04604041Recruiting
Study early warning signs in relapsing-remitting multiple sclerosis

This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.

Split
NCT07769294Not yet recruiting
Blood test for nerve damage in multiple sclerosis and stroke

This study looks at tiny particles in the blood that may show how much nerve damage has happened. It aims to find a simple blood test to help doctors understand and monitor conditions like multiple sclerosis and stroke.

NCT06432686Not yet recruiting
Electrical nerve stimulation for multiple sclerosis symptoms

This study tests whether using a small electrical nerve stimulator on the skin can help improve symptoms of multiple sclerosis (MS), such as pain or numbness. The treatment is non-invasive and may offer a safe way to manage MS symptoms without medication.

NCT07333196Not yet recruiting
Observational study for people with neuroimmune conditions

This study is a long-term observational study—it does not test a new drug but follows people with certain nerve and immune conditions (like multiple sclerosis, myasthenia gravis, and others) to learn more about how these diseases progress. By joining, you help researchers gather valuable data that could improve care for others with similar conditions.

Wuhan, Hubei

Hear when a new Multiple sclerosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.